Nguyen NH, Ohno-Machado L, Sandborn WJ, Singh S
The STEP trials and real-world observational data show that gradual, weekly dose increases of 0.25 mg optimize tolerability and long-term adherence compared to faster escalation protocols
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Pharmacists engaged in compounding are expected to follow applicable standards and regulations for the types of preparations that are compounded
MEDVi Pros Offers brand-name Zepbound and Wegovy alongside compounded options, which NewSelf does not
Recently, there have been promising drug development approaches for the treatment of disorders related to glucose metabolism in the brain and, therefore, against obesity-associated diseases